Imposing RCTs For Supplement Claims Would Cause 'Wholesale Change' In Regulation – CRN, CHPA
This article is powered by The Rose Sheet
Executive Summary
“The industry would face confusion as to the appropriate substantiation standard for non-disease dietary supplement claims,” say the Council for Responsible Nutrition and the Consumer Healthcare Products Association in a joint amicus brief filed with in Second Circuit. They submitted the brief in support of Quincy’s motion urging the appeals court to dismiss an appeal by FTC and New York of a federal district court’s 2017 dismissal of the federal and state agencies' complaint against Quincy.
You may also be interested in...
FTC's Prevagen Complaint Revived: Court Says 'Deceptive' Ad Allegation Plausible
District court erred in dismissing FTC complaint that Prevagen marketer Quincy Biosciences used deceptive representations in ads, Second Circuit says in long-awaited order. FTC and New York attorney general, along with advocacy group TINA, criticize Quincy's post hoc data analyses finding "false positives."
Sweeping Change At FTC May Sweep Away RCT Standard For Health Claims
Confirmations by the Senate mark FTC ’s first-ever complete leadership turnover at once and fill out the roster for the first time since President Trump’s election in 2016. The agency has been operating with two commissioners since soon after the election.
Criminal Case In PR, FTC Appeal In NY, GNC In India: Health And Wellness Industry News
GNC works with Guardian Healthcare Services to grow sales in India; FTC, NY AG appeal dismissal of Prevagen complaint; and a federal grand jury in San Juan returned a 28-count indictment charging four defendants with mail and wire fraud , trafficking in counterfeit goods, distributing a controlled substance, international money laundering and smuggling.